About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 659391, 7 pages
http://dx.doi.org/10.1155/2013/659391
Research Article

Antidepressive-Like Property of Dichloromethane Fraction of Pimenta pseudocaryophyllus and Relevance of Monoamine Metabolic Enzymes

1Department of Physiological Sciences, Federal University of Goiás, Campus Samambaia, 74001-970 Goiâania, GO, Brazil
2Laboratory of Neuropharmacology, Department of Pharmacology, CEP 88040-970 BLOC D CCB, Federal University of Santa Catarina, UFSC, Florianópolis, SC, Brazil
3Sciences and Technology Unit, Goias State University, BR 153, No. 3105, CEP 75132-903, Fazenda Barreiro do Meio, Anápolis, GO, Brazil
4Faculty of Pharmacy, Federal University of Goiás, Setor Universitário, CEP 74001-970 Goiâania, GO, Brazil
5Department of Physiological Sciences, Institute of Biology, Federal Rural University of Rio de Janeiro, BR465, km 07, Seropédica, 23890-000 Rio de Janeiro, RJ, Brazil

Received 29 September 2012; Revised 6 December 2012; Accepted 6 December 2012

Academic Editor: David Mischoulon

Copyright © 2013 James Oluwagbamigbe Fajemiroye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. R. Landrum, “Monography 45: campomanesia, pimenta, blepharocalyx, legrandia, acca, myrrhinium, and luma (Myrtaceae),” Flora Neotropica, vol. 4, pp. 72–115, 1986.
  2. L. R. Landrum and M. L. Kawasaki, “The genera of Myrtaceae in Brazil: an illustrated synoptic treatment and identification keys,” Brittonia, vol. 49, no. 4, pp. 508–536, 1997. View at Scopus
  3. M. Nakaoka-Sakita, O. T. Aguiar, M. Yatagai, and T. Igarashi, “Óleo essencial de Pimenta pseudocaryophyllus var. pseudocaryophyllus (Gomes) Landrum (Myrtaceae) I: cromatografia a gás/espectrometria de massa (CC/EM),” A Revista do Instituto Florestal, vol. 6, pp. 53–61, 1994.
  4. M. E. L. Lima, I. Cordeiro, M. C. M. Young, M. E. G. Sobra, and P. R. H. Moreno, “Antimicrobial activity of the essential oil from two specimens of Pimenta pseudocaryophyllus (Gomes) L.R. Landrum (Myrtaceae) native from São Paulo State-Brazil,” Pharmacologyonline, vol. 3, pp. 589–593, 2006.
  5. J. A. M. Paula, J. R. Paula, M. T. F. Bara, M. H. Rezende, and H. D. Ferreira, “Pharmacognostic study about Pimenta pseudocaryophyllus (Gomes) L. R. Landrum leaves-Myrtaceae,” Revista Brasileira de Farmacognosia, vol. 18, no. 2, pp. 265–278, 2008. View at Publisher · View at Google Scholar
  6. B. C. B. dos Santos, J. C. T. da Silva, P. G. Guerrero, G. G. Leitão, and L. E. S. Barata, “Isolation of chavibetol from essential oil of Pimenta pseudocaryophyllus leaf by high-speed counter-current chromatography,” Journal of Chromatography A, vol. 1216, no. 19, pp. 4303–4306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. O. Fajemiroye, E. S. Araujo, P. M. Galdino et al., “Alterações comportamentais induzidas pelo óleo essencial extraído das folhas de Pimenta pseudocaryophyllus (Gomes) L. R. Landrum,” in XXI Simpósio de Plantas Medicinais do Brasil. Plantas Medicinais, vol. 121, Utilização e Conservação, Avanços, Brasil, 2010.
  8. J. O. Fajemiroye, P. M. Galdino, S. F. Alves et al., “Involvement of 5-HT1A in the anxiolytic-like effect of dichloromethane fraction of Pimenta pseudocaryophyllus,” Journal of Ethnopharmacology, vol. 3, pp. 872–877, 2012.
  9. J. O. Fajemiroye, J. L. R. Martins, A. F. Brito, J. A. M. Paula, J. R. Paula, and E. A. Costa, “Neuropharmacological activity of Pimenta pseudocaryophyllus (Gomes) L.R. Landrum,” Planta Medica, vol. 77, p. 1401, 2011.
  10. P. Blier, “The pharmacology of putative early-onset antidepressant strategies,” European Neuropsychopharmacology, vol. 13, no. 2, pp. 57–66, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Antony, “Assessment and treatment of social phobia,” Canadian Journal of Psychiatry, vol. 42, pp. 826–834, 1997.
  12. D. V. Sheehan and C. G. Mao, “Paroxetine treatment of generalized anxiety disorder,” Psychopharmacology Bulletin, vol. 37, pp. 64–75, 2003.
  13. J. Zohar and H. G. Westenberg, “Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors,” Acta Psychiatrica Scandinavica, supplement 403, pp. 39–49, 2000.
  14. O. Kalus, G. M. Asnis, E. Rubinson et al., “Desipramine treatment in panic disorder,” Journal of Affective Disorders, vol. 21, no. 4, pp. 239–244, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Katon, “Panic disorder: epidemiology, diagnosis, and treatment in primary care,” Journal of Clinical Psychiatry, vol. 47, pp. 21–30, 1986.
  16. M. W. Jann and N. M. Kurtz, “Treatment of panic and phobic disorders,” Clinical Pharmacy, vol. 6, pp. 947–962, 1987.
  17. M. H. Trivedi, A. J. Rush, T. J. Carmody et al., “Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?” Journal of Clinical Psychiatry, vol. 62, no. 10, pp. 776–781, 2001. View at Scopus
  18. A. J. Rush, M. H. Trivedi, T. J. Carmody et al., “Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline,” Neuropsychopharmacology, vol. 25, no. 1, pp. 131–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Hattesohl, B. Feistel, H. Sievers, R. Lehnfeld, M. Hegger, and H. Winterhoff, “Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties,” Phytomedicine, vol. 15, no. 1-2, pp. 2–15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Braida, V. Capurro, A. Zani et al., “Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents,” British Journal of Pharmacology, vol. 157, no. 5, pp. 844–853, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Steru, R. Chermat, B. Thierry, and P. Simon, “The tail suspension test: a new method for screening antidepressants in mice,” Psychopharmacology, vol. 85, no. 3, pp. 367–370, 1985. View at Scopus
  22. R. D. Porsolt, A. Bertin, and M. Jalfre, “Behavioral despair in mice: a primary screening test for antidepressants,” Archives Internationales de Pharmacodynamie et de Therapie, vol. 229, no. 2, pp. 327–336, 1977. View at Scopus
  23. A. Holt, D. F. Sharman, G. B. Baker, and M. M. Palcic, “A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates,” Analytical Biochemistry, vol. 244, no. 2, pp. 384–392, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Zhou, X. Li, Z. Qiu, and G. Liu, “Effect of leaves of Apocynum venetum L. on the activity of MAO in mice,” Journal of Medicinal Plant Research, vol. 5, no. 12, pp. 2584–2586, 2011. View at Scopus
  25. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Scopus
  26. G. B. Drummond and B. D. M. Tom, “How can we tell if frogs jump further?” British Journal of Pharmacology, vol. 164, pp. 209–212, 2011. View at Publisher · View at Google Scholar
  27. G. B. Drummond and B. D. M. Tom, “Statistics, probability, significance, likelihood: words mean what we define them to mean,” British Journal of Pharmacology, vol. 164, pp. 1573–1576, 2011. View at Publisher · View at Google Scholar
  28. J. A. M. Paula, M. R. R. Silva, M. P. Costa et al., “Phytochemical analysis and antimicrobial, antinociceptive, and anti-inflammatory activities of two chemotypes of Pimenta pseudocaryophyllus (Myrtaceae),” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 420715, 15 pages, 2012. View at Publisher · View at Google Scholar
  29. T. J. Connor, J. P. Kelly, and B. E. Leonard, “Forced swim test-induced endocrine and immune changes in the rat: Effect of subacute desipramine treatment,” Pharmacology Biochemistry and Behavior, vol. 59, no. 1, pp. 171–177, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. J. F. Cryan, A. Markou, and I. Lucki, “Assessing antidepressant activity in rodents: recent developments and future needs,” Trends in Pharmacological Sciences, vol. 23, no. 5, pp. 238–245, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Frazer and S. Benmansour, “Delayed pharmacological effects of antidepressants,” Molecular Psychiatry, vol. 7, pp. S23–S28, 2002. View at Publisher · View at Google Scholar
  32. J. C. Nelson, C. M. Mazure, P. I. Jatlow, M. B. Bowers Jr., and L. H. Price, “Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study,” Biological Psychiatry, vol. 55, no. 3, pp. 296–300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. L. Wong and J. Licinio, “Research and treatment approaches to depression,” Nature Reviews Neuroscience, vol. 2, pp. 343–351, 2001. View at Publisher · View at Google Scholar
  34. M. Geyer and A. Markou, “Secondary animal models of psychiatric disorders,” in Psychopharmacology: The Fourth Generation of Progress, F. Bloom and D. Kupfer, Eds., pp. 787–798, Raven Press, New York, NY, USA, 1995.
  35. A. P. West, “Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 14, pp. 863–877, 1990. View at Publisher · View at Google Scholar
  36. V. Castagné, P. Moser, S. Roux, and R. D. Porsolt, “Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice,” Current Protocols in Neuroscience. In press. View at Publisher · View at Google Scholar
  37. M. J. Detke, J. Johnson, and I. Lucki, “Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression,” Experimental and Clinical Psychopharmacology, vol. 5, no. 2, pp. 107–112, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. S. R. Bodnoff, B. Suranyi-Cadotte, D. H. Aitken, R. Quirion, and M. J. Meaney, “The effects of chronic antidepressant treatment in an animal model of anxiety,” Psychopharmacology, vol. 95, no. 3, pp. 298–302, 1988. View at Scopus
  39. G. F. Aragão, L. M. V. Carneiro, A. P. F. Junior et al., “A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March,” Pharmacology Biochemistry and Behavior, vol. 85, no. 4, pp. 827–834, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Zhou, Y. H. Shen, C. Zhang, J. Su, R. H. Liu, and W. D. Zhang, “Triterpene saponins from Bacopa monnieri and their antidepressant effects in two mice models,” Journal of Natural Products, vol. 70, no. 4, pp. 652–655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. J. L. Maia, R. C. P. Lima-Júnior, J. P. David, J. M. David, F. A. Santos, and V. S. Rao, “Oleanolic acid, a pentacyclic triterpene attenuates the mustard oil-induced colonic nociception in mice,” Biological and Pharmaceutical Bulletin, vol. 29, no. 1, pp. 82–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. D. S. Charney, “Monoamine dysfunction and the pathophysiology and treatment of depression,” Journal of Clinical Psychiatry, vol. 59, pp. 11–14, 1998.
  43. H. L. Miller, P. L. Delgado, R. M. Salomon et al., “Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression,” Archives of General Psychiatry, vol. 53, no. 2, pp. 117–128, 1996. View at Scopus
  44. Z. Zhao, M. A. Baros, H. Zhang et al., “Norepinephrine transporter regulation mediates the long- term behavioral effects of the antidepressant desipramine,” Neuropsychopharmacology, vol. 33, pp. 3190–3200, 2008. View at Publisher · View at Google Scholar
  45. P. M. Whitaker-Azmitia, A. Borella, and N. Raio, “Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2. A new animal model of schizophrenia,” Neuropsychopharmacology, vol. 12, no. 3, pp. 269–272, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. H. L. Miller, P. L. Delgado, R. M. Salomon, G. R. Heninger, and D. S. Charnery, “Effects of alpha-methyl-para-tyrosine (AMPT) in drug free depressed patients,” Neuropsychopharmacology, vol. 14, pp. 151–157, 1996. View at Publisher · View at Google Scholar
  47. R. W. Lam, E. M. Tam, A. Grewal, and L. N. Yatham, “Effects of alpha-methyl-para-tyrosine-induced catecholamine depletion in patients with seasonal affective disorder in summer remission,” Neuropsychopharmacology, vol. 25, no. 5, pp. S97–S101, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. R. M. Salomon, H. L. Miller, P. L. Delgado, and D. Charney, “The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders,” International Clinical Psychopharmacology, supplement 2, pp. 41–46, 1993.
  49. M. J. Millan, “Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application,” Pharmacology & Therapeutics, vol. 110, pp. 135–370, 2006. View at Publisher · View at Google Scholar
  50. J. Knoll, “The history of (-)deprenyl the first selective inhibitor of type B monoamine oxidase,” Voprosy Meditsinskoj Khimii, vol. 43, no. 6, pp. 490–493, 1997. View at Scopus
  51. J. Wouters, “Structural aspect of monoamine oxidaseand its reversible inhibition,” Current Medicinal Chemistry, vol. 5, pp. 137–162, 1988.
  52. V. Butterweck, “Mechanism of action of St John's wort in depression: what is known?” CNS Drugs, vol. 17, no. 8, pp. 539–562, 2003. View at Scopus
  53. D. L. Murphy, F. Karoum, D. Pickar et al., “Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline),” Journal of Neural Transmission, supplement 52, pp. 39–48, 1998. View at Scopus
  54. A. D. Williams, “Antidepressants,” in Principles of Medicinal Chemistry, pp. 590–591, Lippincott Williams & Wilkins, Hagerstwon, Md, USA, 2007.